RELEVIUM’S BIOCANNABIX POSITIONS ITSELF AS AN IMPORTANT PLAYER IN COLOMBIA AS IT PURSUES ENDO-MEDICAL CANNABIS STRATEGY FOR LATIN AMERICA
Montreal, QC – June 25, 2019 –– Relevium Technologies Inc. (TSX-V: RLV) (OTCQB: RLLVF) (Frankfurt: 6BX) (the “Company” or “Relevium”), a Health and Wellness portfolio company, announced today it is positioning itself as an important player in the Colombian medical cannabis market by cementing medical and research relationships in the country in order to establish […]
Relevium to Hold Investor Call to Discuss LATAM Strategy June 28, 2019 at 1:00pm EST
Montreal, Canada – June 19, 2019 – Relevium Technologies Inc. a Health and Wellness portfolio company listed on TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX” (the “Company” or “Relevium”), is pleased to announce it will be holding a shareholder and investor conference call to discuss its Latin American (LATAM) strategy and the upside potential of its recently […]
Relevium Takes Major Step in Latam to Acquire Lifeline Pharma in Cali, Colombia
Montreal, Canada – June 13, 2019 – Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that Biocannabix Health Corporation (“Biocannabix”), a wholly-owned subsidiary of Relevium has executed on June 12, 2019 a binding agreement to acquire the shares of Lifeline Pharma SAS, a Cali based […]
